March 31 2023
As we move to COVID-19 infections being part of our business as usual, this service closed on 31st March 2023 and will no longer provide patient monitoring or clinical advice.
Posted March 29, 2022
ATAGI recommends an additional booster dose of COVID-19 vaccine be provided to people who are at greatest risk of severe illness from COVID-19. These people will have received their primary vaccination and first booster dose prior to receiving the winter dose. The groups are:
The additional winter booster dose can be given from 4 months or longer after the person has received their first booster dose, or from 4 months after a confirmed SARS-CoV-2 infection, if infection occurred since the person’s first COVID-19 booster dose.
ATAGI recommends that the rollout of the additional booster dose for these groups starts from April 2022, coinciding with the rollout of the 2022 influenza vaccination program.
Influenza vaccine can be co-administered with the additional booster dose of COVID-19 vaccine. However, if a person is not yet eligible for their additional booster dose, influenza vaccine could be given ahead of the additional booster dose.
Subscribe to our mailing list to get all the latest news updates delivered to your inbox.